Company Filing History:
16 out of 3,684 
1 out of 41 
1 out of 1 Years Active: 2005-2013
Title: Innovations by Gabriel A Mintier: Pioneering Advances in Molecular Biology
Introduction: Gabriel A Mintier, located in Hightstown, NJ, has made significant contributions to the field of molecular biology with an impressive portfolio of 19 patents. His work primarily focuses on innovative polynucleotides and their applications in medical diagnostics and therapeutic treatments, showcasing his commitment to advancing healthcare technologies.
Latest Patents: Among his notable inventions are two cutting-edge patents. The first, titled "Polynucleotides encoding novel PCSK9 variants," provides novel polynucleotides encoding the PCSK9b and PCSK9c polypeptides. This invention includes vectors, host cells, antibodies, and methods for producing the aforementioned polypeptides. It also offers diagnostic and therapeutic methods related to diseases associated with these polypeptides, as well as screening methods for identifying associated agonists and antagonists.
The second patent, "Splice variants of human G-protein coupled receptor HGPRBMY29 (HGPRMBY29SV2)," covers polynucleotides encoding HGPRBMY28 and HGPRBMY29 polypeptides, along with their splice variants HGPRBMY29v1 and HGPRBMY29v2. This invention similarly provides vectors, host cells, antibodies, and production methods, alongside diagnostic and therapeutic applications for various health conditions related to these polypeptides.
Career Highlights: Gabriel Mintier has made remarkable strides in his career by working for renowned organizations, including Bristol-Myers Squibb Company. His research and innovations have not only expanded the scientific community's understanding of molecular biology but have also contributed to the development of potential treatments for serious health issues.
Collaborations: Throughout his career, Mintier has collaborated with notable professionals, including John N Feder and Chandra S Ramanathan. These collaborations have played a crucial role in enhancing the scope and impact of his research, leading to pioneering advancements in the field.
Conclusion: Gabriel A Mintier stands out as an influential inventor within molecular biology, with a significant number of patents that underscore his innovative contributions. His work on novel polynucleotides and therapeutic methods reflects his dedication to improving healthcare solutions, making strides that could benefit patients worldwide. As the field continues to evolve, Mintier's inventions provide a foundation for future medical advancements and inspire upcoming generations of researchers and inventors.